封面
市场调查报告书
商品编码
1627983

联合重建设备市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Joint Reconstruction Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球关节重建器材市场在 2023 年达到 196 亿美元,预计 2024 年至 2032 年复合年增长率为 4.5%。人口老化以及骨关节炎和类风湿性关节炎等关节相关疾病的增加等因素推动了重建手术的需求。此外,由于健身和体育活动日益普及,年轻人中与运动相关的伤害增加,进一步提振了市场。

科技创新正在改变联合重建设备的面貌。生物相容性材料、3D 列印和植入物设计的进步正在增强设备的耐用性和功能性,从而带来更好的手术结果和患者满意度。这些发展正在扩大联合重建手术对不同年龄层的吸引力。

市场依关节类型分为膝关节、髋关节、肩关节、踝关节置换物及其他产品。膝关节置换市场预计将以5.1% 的复合年增长率成长,到2032 年将超过145 亿美元。 ,特别是在老年人。由于对手术干预来解决进行性关节损伤的需求不断增加,膝关节置换术仍然是首选的关节重建手术。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 196 亿美元
预测值 291 亿美元
复合年增长率 4.5%

根据最终用途,市场分为医院和诊所、流动中心等。 2023 年,医院和诊所在这一领域占据主导地位,预计到2032 年将达到207 亿美元。的病例。他们全面的资源可以实现精确且有效率的手术,尤其是大型联合手术。

2023 年,北美市场收入达105 亿美元,2024 年至2032 年复合年增长率预计为3.4%。增加骨质疏鬆症。生活方式因素,包括高肥胖率和久坐习惯,也会导致关节退化,增加重建手术的需求。强大的医疗基础设施和技术采用进一步支持北美市场的成长。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 老年人口基数不断增加
      • 骨科疾病盛行率增加
      • 技术进步
      • 关节重建手术的成长率
      • 需要个性化和患者特定的植入物
    • 产业陷阱与挑战
      • 设备成本高
      • 严格的 FDA 法规
      • 术后併发症
  • 成长潜力分析
  • 技术景观
  • 供应链分析
  • 未来市场趋势
  • 监管环境
  • 报销场景
  • 投资概况
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按联合类型,2021 - 2032

  • 主要趋势
  • 膝关节置换术
    • 副产品
      • 主要膝关节系统
      • 部分膝关节系统
      • 膝关节翻修系统
    • 按成分
      • 股骨组件
      • 胫骨组件
      • 髌骨组件
  • 髋关节置换术
    • 副产品
      • 初级髋关节重建装置
      • 髋关节重建修復装置
      • 部分髋关节重建装置
      • 髋关节表面置换设备
    • 按成分
      • 髋臼组件
      • 股骨组件
  • 肩关节置换术
    • 肩关节置换术表面置换植入物
    • 肩关节置换创伤植入物
    • 肩关节置换平台植入物
  • 踝关节置换术
    • 两部件固定轴承
    • 三部件移动轴承
  • 其他接头类型

第 6 章:市场估计与预测:依最终用途,2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • ASC
  • 其他最终用户

第 7 章:市场估计与预测:按地区划分,2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 8 章:公司简介

  • Aesculap Implant Systems
  • Allegra Orthopedic
  • Amplitude Ortho
  • Arthrex
  • CONMED
  • DJO Global
  • Exactech
  • Globus Medical
  • Integra LifeSciences
  • Johnson & Johnson
  • Medacta International
  • Microport
  • NuVasive
  • Smith & Nephew
  • Stryker
  • Zimmer Biomet
简介目录
Product Code: 2823

The Global Joint Reconstruction Devices Market reached USD 19.6 billion in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2032. This growth is fueled by the increasing prevalence of joint disorders and injuries worldwide. Factors such as the aging population and the rise in joint-related conditions like osteoarthritis and rheumatoid arthritis drive demand for reconstructive procedures. Additionally, an uptick in sports-related injuries among younger demographics, fueled by the growing popularity of fitness and athletic activities, has further boosted the market.

Technological innovations are transforming the landscape of joint reconstruction devices. Advances in biocompatible materials, 3D printing, and implant design are enhancing the durability and functionality of devices, leading to better surgical outcomes and patient satisfaction. These developments are expanding the appeal of joint reconstruction surgeries across diverse age groups.

The market is segmented by joint type into knee, hip, shoulder, ankle replacements, and other products. The knee replacement segment is poised to grow at a CAGR of 5.1%, surpassing USD 14.5 billion by 2032. High demand in this segment stems from the widespread prevalence of knee-related conditions that impair mobility and quality of life, particularly among the elderly. Knee replacements remain the preferred joint reconstruction surgeries, driven by the increasing need for surgical interventions to address progressive joint damage.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$19.6 Billion
Forecast Value$29.1 Billion
CAGR4.5%

By end use, the market is categorized into hospitals & clinics, ambulatory centers, and others. Hospitals and clinics dominated the segment in 2023, projected to reach USD 20.7 billion by 2032. These facilities are preferred for joint reconstruction surgeries due to their ability to manage complex cases with advanced tools, robotic systems, and cutting-edge imaging technologies. Their comprehensive resources enable precise and efficient procedures, especially for major joint surgeries.

North America accounted for USD 10.5 billion in market revenue in 2023 and is set to grow at a CAGR of 3.4% from 2024 to 2032. The region's market expansion is primarily driven by the aging population, leading to a rise in joint conditions like osteoarthritis and osteoporosis. Lifestyle factors, including high obesity rates and sedentary habits, are also contributing to joint degeneration, increasing the demand for reconstruction procedures. Robust healthcare infrastructure and technological adoption further support market growth in North America.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing base of geriatric population
      • 3.2.1.2 Increasing prevalence of orthopedic diseases
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Growing rate of joint reconstruction surgeries
      • 3.2.1.5 Need for personalized and patient specific implants
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of the devices
      • 3.2.2.2 Stringent FDA regulations
      • 3.2.2.3 Post-surgical complications
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Supply chain analysis
  • 3.6 Future market trends
  • 3.7 Regulatory landscape
  • 3.8 Reimbursement scenario
  • 3.9 Investment overview
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Joint Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Knee replacement
    • 5.2.1 By product
      • 5.2.1.1 Primary knee systems
      • 5.2.1.2 Partial knee systems
      • 5.2.1.3 Revision knee systems
    • 5.2.2 By component
      • 5.2.2.1 Femoral component
      • 5.2.2.2 Tibial component
      • 5.2.2.3 Patellar component
  • 5.3 Hip Replacement
    • 5.3.1 By product
      • 5.3.1.1 Primary hip reconstruction devices
      • 5.3.1.2 Revision hip reconstruction devices
      • 5.3.1.3 Partial hip reconstruction devices
      • 5.3.1.4 Hip resurfacing devices
    • 5.3.2 By component
      • 5.3.2.1 Acetabular component
      • 5.3.2.2 Femoral component
  • 5.4 Shoulder Replacement
    • 5.4.1 Shoulder arthroplasty resurfacing implants
    • 5.4.2 Shoulder arthroplasty trauma implants
    • 5.4.3 Shoulder arthroplasty platform implants
  • 5.5 Ankle Replacement
    • 5.5.1 Two-component fixed bearing
    • 5.5.2 Three-component mobile bearing
  • 5.6 Other joint types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals & clinics
  • 6.3 ASCs
  • 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Aesculap Implant Systems
  • 8.2 Allegra Orthopedic
  • 8.3 Amplitude Ortho
  • 8.4 Arthrex
  • 8.5 CONMED
  • 8.6 DJO Global
  • 8.7 Exactech
  • 8.8 Globus Medical
  • 8.9 Integra LifeSciences
  • 8.10 Johnson & Johnson
  • 8.11 Medacta International
  • 8.12 Microport
  • 8.13 NuVasive
  • 8.14 Smith & Nephew
  • 8.15 Stryker
  • 8.16 Zimmer Biomet